Cotización Moderna - MRNA

	Precios en Tiempo Real	Nivel 2
Forex

Su centro para precios en tiempo real, ideas y debates en vivo

Premium

Último Precio

42.69

Postura de Compra

42.67

Postura de Venta

42.70

Volume Operado de la Acción

1,567,969

42.07 Rango del Día 43.80

35.80 Rango de 52 semanas 170.47

Capitalización de Mercado [m]

16.428B

Precio Anterior

43.06

Precio de Apertura

43.41

Hora

100

42.69

Última hora de negociación

09:46:31

Volumen financiero

US$ 67,429,713

Precio Promedio Ponderado

43.0045

Volumen promedio (3 m)

7,345,594

Acciones en circulación

384,817,811

Rendimiento del Dividendo

Ratio Precio/Utilidad

-3.47

Beneficio por acción (BPA)

-12.25

turnover

6.85B

Beneficio neto

-4.71B

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of ... Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of early 2022, with 25 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases. Mostrar más

Sector

Biological Pds,ex Diagnstics

Industria

Biological Pds,ex Diagnstics

Sitio web

www.modernatx.com

Sede

Wilmington, Delaware, USA

Fundado

Moderna Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker MRNA. The last closing price for Moderna was US$43.06. Over the last year, Moderna shares have traded in a share price range of US$ 35.80 to US$ 170.47.

Moderna currently has 384,817,811 shares in issue. The market capitalisation of Moderna is US$16.57 billion. Moderna has a price to earnings ratio (PE ratio) of -3.47.

Flujo General

Pesimista

Prima Neta

-147M

Calls / Puts

24.39%

Comp. / Vent.

95.83%

OTM / ITM

15.91%

Sweeps Ratio

Merck and Moderna Initiate Phase 3 Trial Evaluating Adjuvant V940 (mRNA-4157) in Combination with KEYTRUDA® (pembrolizumab) After Neoadjuvant KEYTRUDA and Chemotherapy in Patients With Certain Types of Non-Small Cell Lung Cancer (NSCLC)

The INTerpath-009 clinical trial demonstrates continued expansion of the INTerpath clinical program, as the third Phase 3 trial for the investigational individualized neoantigen therapy, V940...

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	-0.3	-0.697836706211	42.99	46.3	41.47	7855852	43.17655249	CS
4	-11.91	-21.8131868132	54.6	56.695	35.8	11027378	42.74972141	CS
12	-30.79	-41.9025585193	73.48	79.9587	35.8	7345594	52.78466227	CS
26	-97.06	-69.4525939177	139.75	158.82	35.8	5479491	72.80069266	CS
52	-36.87	-46.3423831071	79.56	170.47	35.8	5009498	88.12273683	CS
156	-258.94	-85.8468985181	301.63	321.305	35.8	5162407	135.2294627	CS
260	22.39	110.295566502	20.3	497.17	17.68	9231135	146.0138665	CS

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
SNTISenti Biosciences Inc	US$ 15.0155 (595.16%)	82.12M
PPBTPurple Biotech Ltd	US$ 10.87 (223.99%)	23.37M
PRZOParaZero Technologies Ltd	US$ 1.8683 (50.67%)	72.21M
FOSLFossil Group Inc	US$ 2.0992 (43.78%)	13.38M
SMCXDefiance Daily Target 2X Long SMCI ETF	US$ 71.2225 (40.73%)	2.48M
MONDMondee Holdings Inc	US$ 0.44 (-38.05%)	798.07k
LGHLWLion Group Holding Ltd	US$ 0.007 (-21.35%)	25.71k
IMCCIM Cannabis Corporation	US$ 3.1602 (-20.80%)	115.72k
SMTKSmartKem Inc	US$ 5.00 (-20.26%)	69.24k
INVZWInnoviz Technologies Ltd	US$ 0.0759 (-20.11%)	1.98k
XTIAXTI Aerospace Inc	US$ 0.0467 (4.01%)	125.87M
SMCISuper Micro Computer Inc	US$ 39.321 (20.47%)	85.71M
SNTISenti Biosciences Inc	US$ 15.0416 (596.37%)	81.13M
RGTIRigetti Computing Inc	US$ 3.0501 (0.00%)	78.09M
SGBXSafe and Green Holdings Corporation	US$ 0.673 (37.35%)	71.53M